Answers are grounded in this paper and cite their sources.
In diabetes haptoglobin (Hp) 2 vs Hp 1 allelic product is associated with cardiac and renal complications. Few studies report both Hp phenotype and Hp levels. In a Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) trial substudy we evaluated the Hp phenotype, Hp levels, and fenofibrate effects.
No takes yet. Share an insight, caveat, or question.
Januszewski et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: